| Reconstitution of HIV-specific Immunity Against HIV (NCT02563509) | Guangzhou 8th People's Hospital | 2016-01-01 |
| The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production (NCT02871648) | Brigham and Women's Hospital | 2016-01-01 |
| Fentanyl Sublingual Spray in Opioid Naive Participants (NCT02641340) | INSYS Therapeutics Inc | 2016-01-01 |
| A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 (NCT02651753) | Chong Kun Dang Pharmaceutical | 2016-01-01 |
| Citalopram for Sx/Util in Acute Coronary Syndrome Patients (NCT01667744) | Henry Ford Health System | 2016-01-01 |
| Intraoperative Imaging of Pulmonary Adenocarcinoma (NCT02653612) | VA Office of Research and Development | 2016-01-01 |
| Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain (NCT02767349) | Mallinckrodt | 2016-01-01 |
| Effect of Tea Consumption on Steroid Profile in Healthy Volunteers (NCT02779361) | Parc de Salut Mar | 2016-01-01 |
| High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin (NCT02630303) | Jared Jagdeo, MD, MS | 2016-01-01 |
| Repeated Mesenchymal Stem Cell Injections in ALS (NCT04821479) | Hadassah Medical Organization | 2016-01-01 |
| Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD) (NCT00517907) | Hadassah Medical Organization | 2016-01-01 |
| Low-dose Ketamine for Acute Pain in the Emergency Department (NCT03017248) | Faculty of Medicine, Sousse | 2016-01-01 |
| Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery (NCT02703376) | Nagasaki University | 2016-01-01 |
| Mass Balance and Metabolism Study of 14C-Z-215 (NCT02618629) | Zeria Pharmaceutical | 2016-01-01 |
| Acupoint Massage Combined With Ear Point Pressing Beans (NCT06650917) | Hai'an Hospital of TCM001 | 2016-01-01 |
| Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia (NCT02589340) | Oregon Health and Science University | 2016-01-01 |
| Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas (NCT02973672) | Surgimab | 2016-01-01 |
| MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age (NCT02582359) | Massachusetts General Hospital | 2016-01-01 |
| SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma (NCT02661022) | Stemline Therapeutics, Inc. | 2016-01-01 |
| A Study of LY3039478 in Healthy Participants (NCT02659865) | Eli Lilly and Company | 2016-01-01 |
| NUC-3373 in Advanced Solid Tumours (NCT02723240) | University of Oxford | 2016-01-01 |
| Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas (NCT02661542) | Fujifilm Pharmaceuticals U.S.A., Inc. | 2016-01-01 |
| Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older (NCT02647190) | Memorial Sloan Kettering Cancer Center | 2016-01-01 |
| Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia (NCT02822326) | Guangdong Provincial People's Hospital | 2016-01-01 |
| Improving Prognosis in HIV Infection (NCT02640625) | Oslo University Hospital | 2016-01-01 |
| Effect of Buccal Fat Pad Derived Stem Cells in Maxillary Sinus Augmentation (NCT02745379) | Shahid Beheshti University of Medical Sciences | 2016-01-01 |
| Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose) (NCT02537938) | NeuroGenetic Pharmaceuticals Inc | 2016-01-01 |
| MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT (NCT02528682) | Radboud University Medical Center | 2016-01-01 |
| Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV (NCT02579083) | KBio Inc | 2016-01-01 |
| Study of rSIFN-co for Patients With Advanced Solid Tumors (NCT02464007) | Sichuan Huiyang Life Science and Technology Corporation | 2016-01-01 |
| Effectiveness and Safety of Adipose-derived Regenerative Cells for Reduction of Risk of Bladder Neck Contracture (NCT02869061) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2016-01-01 |
| K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability (NCT02720666) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2016-01-01 |
| A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects (NCT02650076) | Sanwa Kagaku Kenkyusho Co., Ltd. | 2016-01-01 |
| Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer (NCT02646358) | Mast Therapeutics, Inc. | 2016-01-01 |
| Cognitive Processing Therapy vs. Sertraline for the Treatment of PTSD & SUD in Egyptian Patients (NCT03469128) | British University In Egypt | 2016-01-01 |
| PTC596 in Patients With Advanced Solid Tumors (NCT02404480) | PTC Therapeutics | 2016-01-01 |
| A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer (NCT02671955) | Janssen Research & Development, LLC | 2016-01-01 |
| Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults (NCT02476773) | Baylor College of Medicine | 2016-01-01 |
| Sentinel Node Detection in Ovarian Cancer (NCT02540551) | Maastricht University Medical Center | 2016-01-01 |
| Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults (NCT02658253) | Institut National de la Santé Et de la Recherche Médicale, France | 2016-01-01 |
| A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers (NCT02663999) | Acorda Therapeutics | 2016-01-01 |
| Foraminal Enlargement and Postoperative Pain. (NCT02770053) | Isparta Military Hospital | 2016-01-01 |
| Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients (NCT03078257) | The First Affiliated Hospital with Nanjing Medical University | 2016-01-01 |
| The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers (NCT02654522) | Steve Yoelin M.D. Medical Associates, Inc. | 2016-01-01 |
| A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer (NCT02454010) | Fujifilm Pharmaceuticals U.S.A., Inc. | 2016-01-01 |
| Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA (NCT02965911) | Beijing 302 Hospital | 2016-01-01 |
| Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth (NCT02793557) | Follicum AB | 2016-01-01 |
| The Effect of Dopamine on Diabetic Retinopathy (NCT02706977) | Emory University | 2016-01-01 |
| PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers (NCT02783638) | Yuhan Corporation | 2016-01-01 |
| Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer (NCT02605915) | Hoffmann-La Roche | 2015-12-31 |
| Safety and Tolerability Study of BMS-986177 in Healthy Subjects (NCT02608970) | Bristol-Myers Squibb | 2015-12-31 |
| Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma (NCT01961063) | City of Hope Medical Center | 2015-12-31 |
| Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation (NCT02632708) | Institut de Recherches Internationales Servier | 2015-12-31 |
| Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer (NCT02532114) | University of Washington | 2015-12-31 |
| A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma (NCT02631577) | Hoffmann-La Roche | 2015-12-31 |
| Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma (NCT02633059) | Mayo Clinic | 2015-12-30 |
| A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) (NCT02616185) | Pfizer | 2015-12-30 |
| Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia (NCT02538614) | Gilead Sciences | 2015-12-29 |
| Study of INCB053914 in Subjects With Advanced Malignancies (NCT02587598) | Incyte Corporation | 2015-12-29 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). (NCT02622334) | Hoffmann-La Roche | 2015-12-29 |
| Bioavailability Study of SPARC001 in Healthy Adult Volunteers (NCT02618395) | Sun Pharma Advanced Research Company Limited | 2015-12-28 |
| Pharmacokinetics Study in Patients With Impaired Hepatic Function (NCT02586194) | Astellas Pharma Inc | 2015-12-28 |
| A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours (NCT02586987) | AstraZeneca | 2015-12-28 |
| Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours (NCT02617277) | AstraZeneca | 2015-12-28 |
| Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration) (NCT03591133) | Taisho Pharmaceutical Co., Ltd. | 2015-12-24 |
| A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants (NCT02624986) | Hoffmann-La Roche | 2015-12-23 |
| Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants (NCT02640092) | Genentech, Inc. | 2015-12-23 |
| A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02596971) | Hoffmann-La Roche | 2015-12-22 |
| Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects (NCT02310464) | OBI Pharma, Inc | 2015-12-22 |
| A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD (NCT02624778) | Eli Lilly and Company | 2015-12-22 |
| Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults (NCT02718469) | Auro Vaccines LLC | 2015-12-22 |
| Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder (NCT02611921) | Children's Hospital Medical Center, Cincinnati | 2015-12-22 |
| ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors (NCT02551185) | Celgene | 2015-12-22 |
| Study of bb2121 in Multiple Myeloma (NCT02658929) | Celgene | 2015-12-22 |
| HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma (NCT02370160) | Masonic Cancer Center, University of Minnesota | 2015-12-21 |
| Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) (NCT02440789) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-12-21 |
| Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment. (NCT02624557) | Novartis Pharmaceuticals | 2015-12-21 |
| IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency (NCT02636270) | Children's Hospital Medical Center, Cincinnati | 2015-12-21 |
| A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects (NCT02637037) | AstraZeneca | 2015-12-21 |
| A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study (NCT02578797) | Aragon Pharmaceuticals, Inc. | 2015-12-18 |
| A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271 (NCT02724085) | Tetraphase Pharmaceuticals, Inc | 2015-12-18 |
| Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101) (NCT02584634) | Pfizer | 2015-12-18 |
| Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis (NCT02607774) | Novartis Pharmaceuticals | 2015-12-17 |
| High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease (NCT02629120) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-12-17 |
| Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA) (NCT02565992) | Viralytics | 2015-12-17 |
| First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects (NCT02647281) | GlaxoSmithKline | 2015-12-17 |
| A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II) (NCT02662712) | Janssen Sciences Ireland UC | 2015-12-17 |
| Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma (NCT02293109) | Mehrdad Abedi, MD | 2015-12-17 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB) (NCT02526979) | Astellas Pharma Europe B.V. | 2015-12-17 |
| Bioequivalence Study of TNX-102 SL 2.8 mg Sublingual Tablets From Two Manufacturers. (NCT03168022) | Tonix Pharmaceuticals, Inc. | 2015-12-16 |
| A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children (NCT02637687) | Bayer | 2015-12-16 |
| Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B (NCT02618915) | Ultragenyx Pharmaceutical Inc | 2015-12-16 |
| Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant (NCT02668315) | Maisonneuve-Rosemont Hospital | 2015-12-16 |
| CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies (NCT02529813) | M.D. Anderson Cancer Center | 2015-12-16 |
| An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis (NCT02655679) | Vitae Pharmaceuticals, Inc. | 2015-12-15 |
| Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT02159495) | City of Hope Medical Center | 2015-12-15 |
| Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors (NCT02592785) | Bayer | 2015-12-15 |
| Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors (NCT02881190) | RemeGen Co., Ltd. | 2015-12-14 |
| AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa (NCT02556736) | AbbVie | 2015-12-14 |
| Benapenem PK Phase Ib Multiple-dose Study (NCT03578588) | Sihuan Pharmaceutical Holdings Group Ltd. | 2015-12-14 |